Generic Drugs Market - Global Outlook and Forecast 2021-2027
This report contains market size and forecasts of Generic Drugs in global, including the following market information:
Global Generic Drugs Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Generic Drugs Market Sales, 2016-2021, 2022-2027, (K MT)
Global top five Generic Drugs companies in 2020 (%)
The global Generic Drugs market was valued at 293440 million in 2020 and is projected to reach US$ 422940 million by 2027, at a CAGR of 9.6% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Generic Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Generic Drugs Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K MT)
Global Generic Drugs Market Segment Percentages, By Type, 2020 (%)
Global Generic Drugs Market Segment Percentages, By Application, 2020 (%)
Global Generic Drugs Market Segment Percentages, By Region and Country, 2020 (%)
The report also provides analysis of leading market participants including:
Key companies Generic Drugs revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Generic Drugs revenues share in global market, 2020 (%)
Key companies Generic Drugs sales in global market, 2016-2021 (Estimated), (K MT)
Key companies Generic Drugs sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Global Generic Drugs Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Generic Drugs Market Sales, 2016-2021, 2022-2027, (K MT)
Global top five Generic Drugs companies in 2020 (%)
The global Generic Drugs market was valued at 293440 million in 2020 and is projected to reach US$ 422940 million by 2027, at a CAGR of 9.6% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Generic Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Generic Drugs Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K MT)
Global Generic Drugs Market Segment Percentages, By Type, 2020 (%)
- Simple Generic Drugs
- Super Generic Drugs
- Biosimilars
Global Generic Drugs Market Segment Percentages, By Application, 2020 (%)
- CNS
- Cardiovascular
- Genitourinary/Hormonal Drugs
- Respiratory
- Rheumatology
- Diabetes
- Oncology
- Others
Global Generic Drugs Market Segment Percentages, By Region and Country, 2020 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Generic Drugs revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Generic Drugs revenues share in global market, 2020 (%)
Key companies Generic Drugs sales in global market, 2016-2021 (Estimated), (K MT)
Key companies Generic Drugs sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Teva
- Novartis - Sandoz
- Mylan
- Sun Pharmaceutical
- Aspen
- Fresenius Kabi
- Pfizer (Hospira)
- Sanofi
- Aurobindo
- Lupin
- Dr. Reddy's
- Apotex
- Cipla
- ENDO (Par Pharmaceutical)
- Stada Arzneimittel
- Krka Group
- Nichi-Iko Pharmaceutical
- Valeant
- Zydus Cadila
- Hikma
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Generic Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Generic Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL GENERIC DRUGS OVERALL MARKET SIZE
2.1 Global Generic Drugs Market Size: 2021 VS 2027
2.2 Global Generic Drugs Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Generic Drugs Sales (Consumption): 2016-2027
3 COMPANY LANDSCAPE
3.1 Top Generic Drugs Players in Global Market
3.2 Top Global Generic Drugs Companies Ranked by Revenue
3.3 Global Generic Drugs Revenue by Companies
3.4 Global Generic Drugs Sales by Companies
3.5 Global Generic Drugs Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Generic Drugs Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Generic Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Generic Drugs Players in Global Market
3.8.1 List of Global Tier 1 Generic Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Generic Drugs Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Generic Drugs Market Size Markets, 2021 & 2027
4.1.2 Simple Generic Drugs
4.1.3 Super Generic Drugs
4.1.4 Biosimilars
4.2 By Type - Global Generic Drugs Revenue & Forecasts
4.2.1 By Type - Global Generic Drugs Revenue, 2016-2021
4.2.2 By Type - Global Generic Drugs Revenue, 2022-2027
4.2.3 By Type - Global Generic Drugs Revenue Market Share, 2016-2027
4.3 By Type - Global Generic Drugs Sales & Forecasts
4.3.1 By Type - Global Generic Drugs Sales, 2016-2021
4.3.2 By Type - Global Generic Drugs Sales, 2022-2027
4.3.3 By Type - Global Generic Drugs Sales Market Share, 2016-2027
4.4 By Type - Global Generic Drugs Price (Manufacturers Selling Prices), 2016-2027
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Generic Drugs Market Size, 2021 & 2027
5.1.2 CNS
5.1.3 Cardiovascular
5.1.4 Genitourinary/Hormonal Drugs
5.1.5 Respiratory
5.1.6 Rheumatology
5.1.7 Diabetes
5.1.8 Oncology
5.1.9 Others
5.2 By Application - Global Generic Drugs Revenue & Forecasts
5.2.1 By Application - Global Generic Drugs Revenue, 2016-2021
5.2.2 By Application - Global Generic Drugs Revenue, 2022-2027
5.2.3 By Application - Global Generic Drugs Revenue Market Share, 2016-2027
5.3 By Application - Global Generic Drugs Sales & Forecasts
5.3.1 By Application - Global Generic Drugs Sales, 2016-2021
5.3.2 By Application - Global Generic Drugs Sales, 2022-2027
5.3.3 By Application - Global Generic Drugs Sales Market Share, 2016-2027
5.4 By Application - Global Generic Drugs Price (Manufacturers Selling Prices), 2016-2027
6 SIGHTS BY REGION
6.1 By Region - Global Generic Drugs Market Size, 2021 & 2027
6.2 By Region - Global Generic Drugs Revenue & Forecasts
6.2.1 By Region - Global Generic Drugs Revenue, 2016-2021
6.2.2 By Region - Global Generic Drugs Revenue, 2022-2027
6.2.3 By Region - Global Generic Drugs Revenue Market Share, 2016-2027
6.3 By Region - Global Generic Drugs Sales & Forecasts
6.3.1 By Region - Global Generic Drugs Sales, 2016-2021
6.3.2 By Region - Global Generic Drugs Sales, 2022-2027
6.3.3 By Region - Global Generic Drugs Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Generic Drugs Revenue, 2016-2027
6.4.2 By Country - North America Generic Drugs Sales, 2016-2027
6.4.3 US Generic Drugs Market Size, 2016-2027
6.4.4 Canada Generic Drugs Market Size, 2016-2027
6.4.5 Mexico Generic Drugs Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Generic Drugs Revenue, 2016-2027
6.5.2 By Country - Europe Generic Drugs Sales, 2016-2027
6.5.3 Germany Generic Drugs Market Size, 2016-2027
6.5.4 France Generic Drugs Market Size, 2016-2027
6.5.5 U.K. Generic Drugs Market Size, 2016-2027
6.5.6 Italy Generic Drugs Market Size, 2016-2027
6.5.7 Russia Generic Drugs Market Size, 2016-2027
6.5.8 Nordic Countries Generic Drugs Market Size, 2016-2027
6.5.9 Benelux Generic Drugs Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Generic Drugs Revenue, 2016-2027
6.6.2 By Region - Asia Generic Drugs Sales, 2016-2027
6.6.3 China Generic Drugs Market Size, 2016-2027
6.6.4 Japan Generic Drugs Market Size, 2016-2027
6.6.5 South Korea Generic Drugs Market Size, 2016-2027
6.6.6 Southeast Asia Generic Drugs Market Size, 2016-2027
6.6.7 India Generic Drugs Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Generic Drugs Revenue, 2016-2027
6.7.2 By Country - South America Generic Drugs Sales, 2016-2027
6.7.3 Brazil Generic Drugs Market Size, 2016-2027
6.7.4 Argentina Generic Drugs Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Generic Drugs Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Generic Drugs Sales, 2016-2027
6.8.3 Turkey Generic Drugs Market Size, 2016-2027
6.8.4 Israel Generic Drugs Market Size, 2016-2027
6.8.5 Saudi Arabia Generic Drugs Market Size, 2016-2027
6.8.6 UAE Generic Drugs Market Size, 2016-2027
7 MANUFACTURERS & BRANDS PROFILES
7.1 Teva
7.1.1 Teva Corporate Summary
7.1.2 Teva Business Overview
7.1.3 Teva Generic Drugs Major Product Offerings
7.1.4 Teva Generic Drugs Sales and Revenue in Global (2016-2021)
7.1.5 Teva Key News
7.2 Novartis - Sandoz
7.2.1 Novartis - Sandoz Corporate Summary
7.2.2 Novartis - Sandoz Business Overview
7.2.3 Novartis - Sandoz Generic Drugs Major Product Offerings
7.2.4 Novartis - Sandoz Generic Drugs Sales and Revenue in Global (2016-2021)
7.2.5 Novartis - Sandoz Key News
7.3 Mylan
7.3.1 Mylan Corporate Summary
7.3.2 Mylan Business Overview
7.3.3 Mylan Generic Drugs Major Product Offerings
7.3.4 Mylan Generic Drugs Sales and Revenue in Global (2016-2021)
7.3.5 Mylan Key News
7.4 Sun Pharmaceutical
7.4.1 Sun Pharmaceutical Corporate Summary
7.4.2 Sun Pharmaceutical Business Overview
7.4.3 Sun Pharmaceutical Generic Drugs Major Product Offerings
7.4.4 Sun Pharmaceutical Generic Drugs Sales and Revenue in Global (2016-2021)
7.4.5 Sun Pharmaceutical Key News
7.5 Aspen
7.5.1 Aspen Corporate Summary
7.5.2 Aspen Business Overview
7.5.3 Aspen Generic Drugs Major Product Offerings
7.5.4 Aspen Generic Drugs Sales and Revenue in Global (2016-2021)
7.5.5 Aspen Key News
7.6 Fresenius Kabi
7.6.1 Fresenius Kabi Corporate Summary
7.6.2 Fresenius Kabi Business Overview
7.6.3 Fresenius Kabi Generic Drugs Major Product Offerings
7.6.4 Fresenius Kabi Generic Drugs Sales and Revenue in Global (2016-2021)
7.6.5 Fresenius Kabi Key News
7.7 Pfizer (Hospira)
7.7.1 Pfizer (Hospira) Corporate Summary
7.7.2 Pfizer (Hospira) Business Overview
7.7.3 Pfizer (Hospira) Generic Drugs Major Product Offerings
7.4.4 Pfizer (Hospira) Generic Drugs Sales and Revenue in Global (2016-2021)
7.7.5 Pfizer (Hospira) Key News
7.8 Sanofi
7.8.1 Sanofi Corporate Summary
7.8.2 Sanofi Business Overview
7.8.3 Sanofi Generic Drugs Major Product Offerings
7.8.4 Sanofi Generic Drugs Sales and Revenue in Global (2016-2021)
7.8.5 Sanofi Key News
7.9 Aurobindo
7.9.1 Aurobindo Corporate Summary
7.9.2 Aurobindo Business Overview
7.9.3 Aurobindo Generic Drugs Major Product Offerings
7.9.4 Aurobindo Generic Drugs Sales and Revenue in Global (2016-2021)
7.9.5 Aurobindo Key News
7.10 Lupin
7.10.1 Lupin Corporate Summary
7.10.2 Lupin Business Overview
7.10.3 Lupin Generic Drugs Major Product Offerings
7.10.4 Lupin Generic Drugs Sales and Revenue in Global (2016-2021)
7.10.5 Lupin Key News
7.11 Dr. Reddy's
7.11.1 Dr. Reddy's Corporate Summary
7.11.2 Dr. Reddy's Generic Drugs Business Overview
7.11.3 Dr. Reddy's Generic Drugs Major Product Offerings
7.11.4 Dr. Reddy's Generic Drugs Sales and Revenue in Global (2016-2021)
7.11.5 Dr. Reddy's Key News
7.12 Apotex
7.12.1 Apotex Corporate Summary
7.12.2 Apotex Generic Drugs Business Overview
7.12.3 Apotex Generic Drugs Major Product Offerings
7.12.4 Apotex Generic Drugs Sales and Revenue in Global (2016-2021)
7.12.5 Apotex Key News
7.13 Cipla
7.13.1 Cipla Corporate Summary
7.13.2 Cipla Generic Drugs Business Overview
7.13.3 Cipla Generic Drugs Major Product Offerings
7.13.4 Cipla Generic Drugs Sales and Revenue in Global (2016-2021)
7.13.5 Cipla Key News
7.14 ENDO (Par Pharmaceutical)
7.14.1 ENDO (Par Pharmaceutical) Corporate Summary
7.14.2 ENDO (Par Pharmaceutical) Business Overview
7.14.3 ENDO (Par Pharmaceutical) Generic Drugs Major Product Offerings
7.14.4 ENDO (Par Pharmaceutical) Generic Drugs Sales and Revenue in Global (2016-2021)
7.14.5 ENDO (Par Pharmaceutical) Key News
7.15 Stada Arzneimittel
7.15.1 Stada Arzneimittel Corporate Summary
7.15.2 Stada Arzneimittel Business Overview
7.15.3 Stada Arzneimittel Generic Drugs Major Product Offerings
7.15.4 Stada Arzneimittel Generic Drugs Sales and Revenue in Global (2016-2021)
7.15.5 Stada Arzneimittel Key News
7.16 Krka Group
7.16.1 Krka Group Corporate Summary
7.16.2 Krka Group Business Overview
7.16.3 Krka Group Generic Drugs Major Product Offerings
7.16.4 Krka Group Generic Drugs Sales and Revenue in Global (2016-2021)
7.16.5 Krka Group Key News
7.17 Nichi-Iko Pharmaceutical
7.17.1 Nichi-Iko Pharmaceutical Corporate Summary
7.17.2 Nichi-Iko Pharmaceutical Business Overview
7.17.3 Nichi-Iko Pharmaceutical Generic Drugs Major Product Offerings
7.17.4 Nichi-Iko Pharmaceutical Generic Drugs Sales and Revenue in Global (2016-2021)
7.17.5 Nichi-Iko Pharmaceutical Key News
7.18 Valeant
7.18.1 Valeant Corporate Summary
7.18.2 Valeant Business Overview
7.18.3 Valeant Generic Drugs Major Product Offerings
7.18.4 Valeant Generic Drugs Sales and Revenue in Global (2016-2021)
7.18.5 Valeant Key News
7.19 Zydus Cadila
7.19.1 Zydus Cadila Corporate Summary
7.19.2 Zydus Cadila Business Overview
7.19.3 Zydus Cadila Generic Drugs Major Product Offerings
7.19.4 Zydus Cadila Generic Drugs Sales and Revenue in Global (2016-2021)
7.19.5 Zydus Cadila Key News
7.20 Hikma
7.20.1 Hikma Corporate Summary
7.20.2 Hikma Business Overview
7.20.3 Hikma Generic Drugs Major Product Offerings
7.20.4 Hikma Generic Drugs Sales and Revenue in Global (2016-2021)
7.20.5 Hikma Key News
8 GLOBAL GENERIC DRUGS PRODUCTION CAPACITY, ANALYSIS
8.1 Global Generic Drugs Production Capacity, 2016-2027
8.2 Generic Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Generic Drugs Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 GENERIC DRUGS SUPPLY CHAIN ANALYSIS
10.1 Generic Drugs Industry Value Chain
10.2 Generic Drugs Upstream Market
10.3 Generic Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Generic Drugs Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Generic Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Generic Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL GENERIC DRUGS OVERALL MARKET SIZE
2.1 Global Generic Drugs Market Size: 2021 VS 2027
2.2 Global Generic Drugs Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Generic Drugs Sales (Consumption): 2016-2027
3 COMPANY LANDSCAPE
3.1 Top Generic Drugs Players in Global Market
3.2 Top Global Generic Drugs Companies Ranked by Revenue
3.3 Global Generic Drugs Revenue by Companies
3.4 Global Generic Drugs Sales by Companies
3.5 Global Generic Drugs Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Generic Drugs Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Generic Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Generic Drugs Players in Global Market
3.8.1 List of Global Tier 1 Generic Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Generic Drugs Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Generic Drugs Market Size Markets, 2021 & 2027
4.1.2 Simple Generic Drugs
4.1.3 Super Generic Drugs
4.1.4 Biosimilars
4.2 By Type - Global Generic Drugs Revenue & Forecasts
4.2.1 By Type - Global Generic Drugs Revenue, 2016-2021
4.2.2 By Type - Global Generic Drugs Revenue, 2022-2027
4.2.3 By Type - Global Generic Drugs Revenue Market Share, 2016-2027
4.3 By Type - Global Generic Drugs Sales & Forecasts
4.3.1 By Type - Global Generic Drugs Sales, 2016-2021
4.3.2 By Type - Global Generic Drugs Sales, 2022-2027
4.3.3 By Type - Global Generic Drugs Sales Market Share, 2016-2027
4.4 By Type - Global Generic Drugs Price (Manufacturers Selling Prices), 2016-2027
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Generic Drugs Market Size, 2021 & 2027
5.1.2 CNS
5.1.3 Cardiovascular
5.1.4 Genitourinary/Hormonal Drugs
5.1.5 Respiratory
5.1.6 Rheumatology
5.1.7 Diabetes
5.1.8 Oncology
5.1.9 Others
5.2 By Application - Global Generic Drugs Revenue & Forecasts
5.2.1 By Application - Global Generic Drugs Revenue, 2016-2021
5.2.2 By Application - Global Generic Drugs Revenue, 2022-2027
5.2.3 By Application - Global Generic Drugs Revenue Market Share, 2016-2027
5.3 By Application - Global Generic Drugs Sales & Forecasts
5.3.1 By Application - Global Generic Drugs Sales, 2016-2021
5.3.2 By Application - Global Generic Drugs Sales, 2022-2027
5.3.3 By Application - Global Generic Drugs Sales Market Share, 2016-2027
5.4 By Application - Global Generic Drugs Price (Manufacturers Selling Prices), 2016-2027
6 SIGHTS BY REGION
6.1 By Region - Global Generic Drugs Market Size, 2021 & 2027
6.2 By Region - Global Generic Drugs Revenue & Forecasts
6.2.1 By Region - Global Generic Drugs Revenue, 2016-2021
6.2.2 By Region - Global Generic Drugs Revenue, 2022-2027
6.2.3 By Region - Global Generic Drugs Revenue Market Share, 2016-2027
6.3 By Region - Global Generic Drugs Sales & Forecasts
6.3.1 By Region - Global Generic Drugs Sales, 2016-2021
6.3.2 By Region - Global Generic Drugs Sales, 2022-2027
6.3.3 By Region - Global Generic Drugs Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Generic Drugs Revenue, 2016-2027
6.4.2 By Country - North America Generic Drugs Sales, 2016-2027
6.4.3 US Generic Drugs Market Size, 2016-2027
6.4.4 Canada Generic Drugs Market Size, 2016-2027
6.4.5 Mexico Generic Drugs Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Generic Drugs Revenue, 2016-2027
6.5.2 By Country - Europe Generic Drugs Sales, 2016-2027
6.5.3 Germany Generic Drugs Market Size, 2016-2027
6.5.4 France Generic Drugs Market Size, 2016-2027
6.5.5 U.K. Generic Drugs Market Size, 2016-2027
6.5.6 Italy Generic Drugs Market Size, 2016-2027
6.5.7 Russia Generic Drugs Market Size, 2016-2027
6.5.8 Nordic Countries Generic Drugs Market Size, 2016-2027
6.5.9 Benelux Generic Drugs Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Generic Drugs Revenue, 2016-2027
6.6.2 By Region - Asia Generic Drugs Sales, 2016-2027
6.6.3 China Generic Drugs Market Size, 2016-2027
6.6.4 Japan Generic Drugs Market Size, 2016-2027
6.6.5 South Korea Generic Drugs Market Size, 2016-2027
6.6.6 Southeast Asia Generic Drugs Market Size, 2016-2027
6.6.7 India Generic Drugs Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Generic Drugs Revenue, 2016-2027
6.7.2 By Country - South America Generic Drugs Sales, 2016-2027
6.7.3 Brazil Generic Drugs Market Size, 2016-2027
6.7.4 Argentina Generic Drugs Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Generic Drugs Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Generic Drugs Sales, 2016-2027
6.8.3 Turkey Generic Drugs Market Size, 2016-2027
6.8.4 Israel Generic Drugs Market Size, 2016-2027
6.8.5 Saudi Arabia Generic Drugs Market Size, 2016-2027
6.8.6 UAE Generic Drugs Market Size, 2016-2027
7 MANUFACTURERS & BRANDS PROFILES
7.1 Teva
7.1.1 Teva Corporate Summary
7.1.2 Teva Business Overview
7.1.3 Teva Generic Drugs Major Product Offerings
7.1.4 Teva Generic Drugs Sales and Revenue in Global (2016-2021)
7.1.5 Teva Key News
7.2 Novartis - Sandoz
7.2.1 Novartis - Sandoz Corporate Summary
7.2.2 Novartis - Sandoz Business Overview
7.2.3 Novartis - Sandoz Generic Drugs Major Product Offerings
7.2.4 Novartis - Sandoz Generic Drugs Sales and Revenue in Global (2016-2021)
7.2.5 Novartis - Sandoz Key News
7.3 Mylan
7.3.1 Mylan Corporate Summary
7.3.2 Mylan Business Overview
7.3.3 Mylan Generic Drugs Major Product Offerings
7.3.4 Mylan Generic Drugs Sales and Revenue in Global (2016-2021)
7.3.5 Mylan Key News
7.4 Sun Pharmaceutical
7.4.1 Sun Pharmaceutical Corporate Summary
7.4.2 Sun Pharmaceutical Business Overview
7.4.3 Sun Pharmaceutical Generic Drugs Major Product Offerings
7.4.4 Sun Pharmaceutical Generic Drugs Sales and Revenue in Global (2016-2021)
7.4.5 Sun Pharmaceutical Key News
7.5 Aspen
7.5.1 Aspen Corporate Summary
7.5.2 Aspen Business Overview
7.5.3 Aspen Generic Drugs Major Product Offerings
7.5.4 Aspen Generic Drugs Sales and Revenue in Global (2016-2021)
7.5.5 Aspen Key News
7.6 Fresenius Kabi
7.6.1 Fresenius Kabi Corporate Summary
7.6.2 Fresenius Kabi Business Overview
7.6.3 Fresenius Kabi Generic Drugs Major Product Offerings
7.6.4 Fresenius Kabi Generic Drugs Sales and Revenue in Global (2016-2021)
7.6.5 Fresenius Kabi Key News
7.7 Pfizer (Hospira)
7.7.1 Pfizer (Hospira) Corporate Summary
7.7.2 Pfizer (Hospira) Business Overview
7.7.3 Pfizer (Hospira) Generic Drugs Major Product Offerings
7.4.4 Pfizer (Hospira) Generic Drugs Sales and Revenue in Global (2016-2021)
7.7.5 Pfizer (Hospira) Key News
7.8 Sanofi
7.8.1 Sanofi Corporate Summary
7.8.2 Sanofi Business Overview
7.8.3 Sanofi Generic Drugs Major Product Offerings
7.8.4 Sanofi Generic Drugs Sales and Revenue in Global (2016-2021)
7.8.5 Sanofi Key News
7.9 Aurobindo
7.9.1 Aurobindo Corporate Summary
7.9.2 Aurobindo Business Overview
7.9.3 Aurobindo Generic Drugs Major Product Offerings
7.9.4 Aurobindo Generic Drugs Sales and Revenue in Global (2016-2021)
7.9.5 Aurobindo Key News
7.10 Lupin
7.10.1 Lupin Corporate Summary
7.10.2 Lupin Business Overview
7.10.3 Lupin Generic Drugs Major Product Offerings
7.10.4 Lupin Generic Drugs Sales and Revenue in Global (2016-2021)
7.10.5 Lupin Key News
7.11 Dr. Reddy's
7.11.1 Dr. Reddy's Corporate Summary
7.11.2 Dr. Reddy's Generic Drugs Business Overview
7.11.3 Dr. Reddy's Generic Drugs Major Product Offerings
7.11.4 Dr. Reddy's Generic Drugs Sales and Revenue in Global (2016-2021)
7.11.5 Dr. Reddy's Key News
7.12 Apotex
7.12.1 Apotex Corporate Summary
7.12.2 Apotex Generic Drugs Business Overview
7.12.3 Apotex Generic Drugs Major Product Offerings
7.12.4 Apotex Generic Drugs Sales and Revenue in Global (2016-2021)
7.12.5 Apotex Key News
7.13 Cipla
7.13.1 Cipla Corporate Summary
7.13.2 Cipla Generic Drugs Business Overview
7.13.3 Cipla Generic Drugs Major Product Offerings
7.13.4 Cipla Generic Drugs Sales and Revenue in Global (2016-2021)
7.13.5 Cipla Key News
7.14 ENDO (Par Pharmaceutical)
7.14.1 ENDO (Par Pharmaceutical) Corporate Summary
7.14.2 ENDO (Par Pharmaceutical) Business Overview
7.14.3 ENDO (Par Pharmaceutical) Generic Drugs Major Product Offerings
7.14.4 ENDO (Par Pharmaceutical) Generic Drugs Sales and Revenue in Global (2016-2021)
7.14.5 ENDO (Par Pharmaceutical) Key News
7.15 Stada Arzneimittel
7.15.1 Stada Arzneimittel Corporate Summary
7.15.2 Stada Arzneimittel Business Overview
7.15.3 Stada Arzneimittel Generic Drugs Major Product Offerings
7.15.4 Stada Arzneimittel Generic Drugs Sales and Revenue in Global (2016-2021)
7.15.5 Stada Arzneimittel Key News
7.16 Krka Group
7.16.1 Krka Group Corporate Summary
7.16.2 Krka Group Business Overview
7.16.3 Krka Group Generic Drugs Major Product Offerings
7.16.4 Krka Group Generic Drugs Sales and Revenue in Global (2016-2021)
7.16.5 Krka Group Key News
7.17 Nichi-Iko Pharmaceutical
7.17.1 Nichi-Iko Pharmaceutical Corporate Summary
7.17.2 Nichi-Iko Pharmaceutical Business Overview
7.17.3 Nichi-Iko Pharmaceutical Generic Drugs Major Product Offerings
7.17.4 Nichi-Iko Pharmaceutical Generic Drugs Sales and Revenue in Global (2016-2021)
7.17.5 Nichi-Iko Pharmaceutical Key News
7.18 Valeant
7.18.1 Valeant Corporate Summary
7.18.2 Valeant Business Overview
7.18.3 Valeant Generic Drugs Major Product Offerings
7.18.4 Valeant Generic Drugs Sales and Revenue in Global (2016-2021)
7.18.5 Valeant Key News
7.19 Zydus Cadila
7.19.1 Zydus Cadila Corporate Summary
7.19.2 Zydus Cadila Business Overview
7.19.3 Zydus Cadila Generic Drugs Major Product Offerings
7.19.4 Zydus Cadila Generic Drugs Sales and Revenue in Global (2016-2021)
7.19.5 Zydus Cadila Key News
7.20 Hikma
7.20.1 Hikma Corporate Summary
7.20.2 Hikma Business Overview
7.20.3 Hikma Generic Drugs Major Product Offerings
7.20.4 Hikma Generic Drugs Sales and Revenue in Global (2016-2021)
7.20.5 Hikma Key News
8 GLOBAL GENERIC DRUGS PRODUCTION CAPACITY, ANALYSIS
8.1 Global Generic Drugs Production Capacity, 2016-2027
8.2 Generic Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Generic Drugs Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 GENERIC DRUGS SUPPLY CHAIN ANALYSIS
10.1 Generic Drugs Industry Value Chain
10.2 Generic Drugs Upstream Market
10.3 Generic Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Generic Drugs Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Generic Drugs in Global Market
Table 2. Top Generic Drugs Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Generic Drugs Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Generic Drugs Revenue Share by Companies, 2016-2021
Table 5. Global Generic Drugs Sales by Companies, (K MT), 2016-2021
Table 6. Global Generic Drugs Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Generic Drugs Price (2016-2021) & (USD/MT)
Table 8. Global Manufacturers Generic Drugs Product Type
Table 9. List of Global Tier 1 Generic Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Generic Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Generic Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Global Generic Drugs Revenue (US$, Mn), 2016-2021
Table 13. By Type - Global Generic Drugs Revenue (US$, Mn), 2022-2027
Table 14. By Type - Global Generic Drugs Sales (K MT), 2016-2021
Table 15. By Type - Global Generic Drugs Sales (K MT), 2022-2027
Table 16. By Application – Global Generic Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 17. By Application - Global Generic Drugs Revenue (US$, Mn), 2016-2021
Table 18. By Application - Global Generic Drugs Revenue (US$, Mn), 2022-2027
Table 19. By Application - Global Generic Drugs Sales (K MT), 2016-2021
Table 20. By Application - Global Generic Drugs Sales (K MT), 2022-2027
Table 21. By Region – Global Generic Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 22. By Region - Global Generic Drugs Revenue (US$, Mn), 2016-2021
Table 23. By Region - Global Generic Drugs Revenue (US$, Mn), 2022-2027
Table 24. By Region - Global Generic Drugs Sales (K MT), 2016-2021
Table 25. By Region - Global Generic Drugs Sales (K MT), 2022-2027
Table 26. By Country - North America Generic Drugs Revenue, (US$, Mn), 2016-2021
Table 27. By Country - North America Generic Drugs Revenue, (US$, Mn), 2022-2027
Table 28. By Country - North America Generic Drugs Sales, (K MT), 2016-2021
Table 29. By Country - North America Generic Drugs Sales, (K MT), 2022-2027
Table 30. By Country - Europe Generic Drugs Revenue, (US$, Mn), 2016-2021
Table 31. By Country - Europe Generic Drugs Revenue, (US$, Mn), 2022-2027
Table 32. By Country - Europe Generic Drugs Sales, (K MT), 2016-2021
Table 33. By Country - Europe Generic Drugs Sales, (K MT), 2022-2027
Table 34. By Region - Asia Generic Drugs Revenue, (US$, Mn), 2016-2021
Table 35. By Region - Asia Generic Drugs Revenue, (US$, Mn), 2022-2027
Table 36. By Region - Asia Generic Drugs Sales, (K MT), 2016-2021
Table 37. By Region - Asia Generic Drugs Sales, (K MT), 2022-2027
Table 38. By Country - South America Generic Drugs Revenue, (US$, Mn), 2016-2021
Table 39. By Country - South America Generic Drugs Revenue, (US$, Mn), 2022-2027
Table 40. By Country - South America Generic Drugs Sales, (K MT), 2016-2021
Table 41. By Country - South America Generic Drugs Sales, (K MT), 2022-2027
Table 42. By Country - Middle East & Africa Generic Drugs Revenue, (US$, Mn), 2016-2021
Table 43. By Country - Middle East & Africa Generic Drugs Revenue, (US$, Mn), 2022-2027
Table 44. By Country - Middle East & Africa Generic Drugs Sales, (K MT), 2016-2021
Table 45. By Country - Middle East & Africa Generic Drugs Sales, (K MT), 2022-2027
Table 46. Teva Corporate Summary
Table 47. Teva Generic Drugs Product Offerings
Table 48. Teva Generic Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 49. Novartis - Sandoz Corporate Summary
Table 50. Novartis - Sandoz Generic Drugs Product Offerings
Table 51. Novartis - Sandoz Generic Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 52. Mylan Corporate Summary
Table 53. Mylan Generic Drugs Product Offerings
Table 54. Mylan Generic Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 55. Sun Pharmaceutical Corporate Summary
Table 56. Sun Pharmaceutical Generic Drugs Product Offerings
Table 57. Sun Pharmaceutical Generic Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 58. Aspen Corporate Summary
Table 59. Aspen Generic Drugs Product Offerings
Table 60. Aspen Generic Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 61. Fresenius Kabi Corporate Summary
Table 62. Fresenius Kabi Generic Drugs Product Offerings
Table 63. Fresenius Kabi Generic Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 64. Pfizer (Hospira) Corporate Summary
Table 65. Pfizer (Hospira) Generic Drugs Product Offerings
Table 66. Pfizer (Hospira) Generic Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 67. Sanofi Corporate Summary
Table 68. Sanofi Generic Drugs Product Offerings
Table 69. Sanofi Generic Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 70. Aurobindo Corporate Summary
Table 71. Aurobindo Generic Drugs Product Offerings
Table 72. Aurobindo Generic Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 73. Lupin Corporate Summary
Table 74. Lupin Generic Drugs Product Offerings
Table 75. Lupin Generic Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 76. Dr. Reddy's Corporate Summary
Table 77. Dr. Reddy's Generic Drugs Product Offerings
Table 78. Dr. Reddy's Generic Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 79. Apotex Corporate Summary
Table 80. Apotex Generic Drugs Product Offerings
Table 81. Apotex Generic Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 82. Cipla Corporate Summary
Table 83. Cipla Generic Drugs Product Offerings
Table 84. Cipla Generic Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 85. ENDO (Par Pharmaceutical) Corporate Summary
Table 86. ENDO (Par Pharmaceutical) Generic Drugs Product Offerings
Table 87. ENDO (Par Pharmaceutical) Generic Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 88. Stada Arzneimittel Corporate Summary
Table 89. Stada Arzneimittel Generic Drugs Product Offerings
Table 90. Stada Arzneimittel Generic Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 91. Krka Group Corporate Summary
Table 92. Krka Group Generic Drugs Product Offerings
Table 93. Krka Group Generic Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 94. Nichi-Iko Pharmaceutical Corporate Summary
Table 95. Nichi-Iko Pharmaceutical Generic Drugs Product Offerings
Table 96. Nichi-Iko Pharmaceutical Generic Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 97. Valeant Corporate Summary
Table 98. Valeant Generic Drugs Product Offerings
Table 99. Valeant Generic Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 100. Zydus Cadila Corporate Summary
Table 101. Zydus Cadila Generic Drugs Product Offerings
Table 102. Zydus Cadila Generic Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 103. Hikma Corporate Summary
Table 104. Hikma Generic Drugs Product Offerings
Table 105. Hikma Generic Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 106. Generic Drugs Production Capacity (K MT) of Key Manufacturers in Global Market, 2019-2021 (K MT)
Table 107. Global Generic Drugs Capacity Market Share of Key Manufacturers, 2019-2021
Table 108. Global Generic Drugs Production by Region, 2016-2021 (K MT)
Table 109. Global Generic Drugs Production by Region, 2022-2027 (K MT)
Table 110. Generic Drugs Market Opportunities & Trends in Global Market
Table 111. Generic Drugs Market Drivers in Global Market
Table 112. Generic Drugs Market Restraints in Global Market
Table 113. Generic Drugs Raw Materials
Table 114. Generic Drugs Raw Materials Suppliers in Global Market
Table 115. Typical Generic Drugs Downstream
Table 116. Generic Drugs Downstream Clients in Global Market
Table 117. Generic Drugs Distributors and Sales Agents in Global Market
Table 1. Key Players of Generic Drugs in Global Market
Table 2. Top Generic Drugs Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Generic Drugs Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Generic Drugs Revenue Share by Companies, 2016-2021
Table 5. Global Generic Drugs Sales by Companies, (K MT), 2016-2021
Table 6. Global Generic Drugs Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Generic Drugs Price (2016-2021) & (USD/MT)
Table 8. Global Manufacturers Generic Drugs Product Type
Table 9. List of Global Tier 1 Generic Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Generic Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Generic Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Global Generic Drugs Revenue (US$, Mn), 2016-2021
Table 13. By Type - Global Generic Drugs Revenue (US$, Mn), 2022-2027
Table 14. By Type - Global Generic Drugs Sales (K MT), 2016-2021
Table 15. By Type - Global Generic Drugs Sales (K MT), 2022-2027
Table 16. By Application – Global Generic Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 17. By Application - Global Generic Drugs Revenue (US$, Mn), 2016-2021
Table 18. By Application - Global Generic Drugs Revenue (US$, Mn), 2022-2027
Table 19. By Application - Global Generic Drugs Sales (K MT), 2016-2021
Table 20. By Application - Global Generic Drugs Sales (K MT), 2022-2027
Table 21. By Region – Global Generic Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 22. By Region - Global Generic Drugs Revenue (US$, Mn), 2016-2021
Table 23. By Region - Global Generic Drugs Revenue (US$, Mn), 2022-2027
Table 24. By Region - Global Generic Drugs Sales (K MT), 2016-2021
Table 25. By Region - Global Generic Drugs Sales (K MT), 2022-2027
Table 26. By Country - North America Generic Drugs Revenue, (US$, Mn), 2016-2021
Table 27. By Country - North America Generic Drugs Revenue, (US$, Mn), 2022-2027
Table 28. By Country - North America Generic Drugs Sales, (K MT), 2016-2021
Table 29. By Country - North America Generic Drugs Sales, (K MT), 2022-2027
Table 30. By Country - Europe Generic Drugs Revenue, (US$, Mn), 2016-2021
Table 31. By Country - Europe Generic Drugs Revenue, (US$, Mn), 2022-2027
Table 32. By Country - Europe Generic Drugs Sales, (K MT), 2016-2021
Table 33. By Country - Europe Generic Drugs Sales, (K MT), 2022-2027
Table 34. By Region - Asia Generic Drugs Revenue, (US$, Mn), 2016-2021
Table 35. By Region - Asia Generic Drugs Revenue, (US$, Mn), 2022-2027
Table 36. By Region - Asia Generic Drugs Sales, (K MT), 2016-2021
Table 37. By Region - Asia Generic Drugs Sales, (K MT), 2022-2027
Table 38. By Country - South America Generic Drugs Revenue, (US$, Mn), 2016-2021
Table 39. By Country - South America Generic Drugs Revenue, (US$, Mn), 2022-2027
Table 40. By Country - South America Generic Drugs Sales, (K MT), 2016-2021
Table 41. By Country - South America Generic Drugs Sales, (K MT), 2022-2027
Table 42. By Country - Middle East & Africa Generic Drugs Revenue, (US$, Mn), 2016-2021
Table 43. By Country - Middle East & Africa Generic Drugs Revenue, (US$, Mn), 2022-2027
Table 44. By Country - Middle East & Africa Generic Drugs Sales, (K MT), 2016-2021
Table 45. By Country - Middle East & Africa Generic Drugs Sales, (K MT), 2022-2027
Table 46. Teva Corporate Summary
Table 47. Teva Generic Drugs Product Offerings
Table 48. Teva Generic Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 49. Novartis - Sandoz Corporate Summary
Table 50. Novartis - Sandoz Generic Drugs Product Offerings
Table 51. Novartis - Sandoz Generic Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 52. Mylan Corporate Summary
Table 53. Mylan Generic Drugs Product Offerings
Table 54. Mylan Generic Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 55. Sun Pharmaceutical Corporate Summary
Table 56. Sun Pharmaceutical Generic Drugs Product Offerings
Table 57. Sun Pharmaceutical Generic Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 58. Aspen Corporate Summary
Table 59. Aspen Generic Drugs Product Offerings
Table 60. Aspen Generic Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 61. Fresenius Kabi Corporate Summary
Table 62. Fresenius Kabi Generic Drugs Product Offerings
Table 63. Fresenius Kabi Generic Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 64. Pfizer (Hospira) Corporate Summary
Table 65. Pfizer (Hospira) Generic Drugs Product Offerings
Table 66. Pfizer (Hospira) Generic Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 67. Sanofi Corporate Summary
Table 68. Sanofi Generic Drugs Product Offerings
Table 69. Sanofi Generic Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 70. Aurobindo Corporate Summary
Table 71. Aurobindo Generic Drugs Product Offerings
Table 72. Aurobindo Generic Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 73. Lupin Corporate Summary
Table 74. Lupin Generic Drugs Product Offerings
Table 75. Lupin Generic Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 76. Dr. Reddy's Corporate Summary
Table 77. Dr. Reddy's Generic Drugs Product Offerings
Table 78. Dr. Reddy's Generic Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 79. Apotex Corporate Summary
Table 80. Apotex Generic Drugs Product Offerings
Table 81. Apotex Generic Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 82. Cipla Corporate Summary
Table 83. Cipla Generic Drugs Product Offerings
Table 84. Cipla Generic Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 85. ENDO (Par Pharmaceutical) Corporate Summary
Table 86. ENDO (Par Pharmaceutical) Generic Drugs Product Offerings
Table 87. ENDO (Par Pharmaceutical) Generic Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 88. Stada Arzneimittel Corporate Summary
Table 89. Stada Arzneimittel Generic Drugs Product Offerings
Table 90. Stada Arzneimittel Generic Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 91. Krka Group Corporate Summary
Table 92. Krka Group Generic Drugs Product Offerings
Table 93. Krka Group Generic Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 94. Nichi-Iko Pharmaceutical Corporate Summary
Table 95. Nichi-Iko Pharmaceutical Generic Drugs Product Offerings
Table 96. Nichi-Iko Pharmaceutical Generic Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 97. Valeant Corporate Summary
Table 98. Valeant Generic Drugs Product Offerings
Table 99. Valeant Generic Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 100. Zydus Cadila Corporate Summary
Table 101. Zydus Cadila Generic Drugs Product Offerings
Table 102. Zydus Cadila Generic Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 103. Hikma Corporate Summary
Table 104. Hikma Generic Drugs Product Offerings
Table 105. Hikma Generic Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 106. Generic Drugs Production Capacity (K MT) of Key Manufacturers in Global Market, 2019-2021 (K MT)
Table 107. Global Generic Drugs Capacity Market Share of Key Manufacturers, 2019-2021
Table 108. Global Generic Drugs Production by Region, 2016-2021 (K MT)
Table 109. Global Generic Drugs Production by Region, 2022-2027 (K MT)
Table 110. Generic Drugs Market Opportunities & Trends in Global Market
Table 111. Generic Drugs Market Drivers in Global Market
Table 112. Generic Drugs Market Restraints in Global Market
Table 113. Generic Drugs Raw Materials
Table 114. Generic Drugs Raw Materials Suppliers in Global Market
Table 115. Typical Generic Drugs Downstream
Table 116. Generic Drugs Downstream Clients in Global Market
Table 117. Generic Drugs Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Generic Drugs Segment by Type
Figure 2. Generic Drugs Segment by Application
Figure 3. Global Generic Drugs Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Generic Drugs Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Generic Drugs Revenue, 2016-2027 (US$, Mn)
Figure 7. Generic Drugs Sales in Global Market: 2016-2027 (K MT)
Figure 8. The Top 3 and 5 Players Market Share by Generic Drugs Revenue in 2020
Figure 9. By Type - Global Generic Drugs Sales Market Share, 2016-2027
Figure 10. By Type - Global Generic Drugs Revenue Market Share, 2016-2027
Figure 11. By Type - Global Generic Drugs Price (USD/MT), 2016-2027
Figure 12. By Application - Global Generic Drugs Sales Market Share, 2016-2027
Figure 13. By Application - Global Generic Drugs Revenue Market Share, 2016-2027
Figure 14. By Application - Global Generic Drugs Price (USD/MT), 2016-2027
Figure 15. By Region - Global Generic Drugs Sales Market Share, 2016-2027
Figure 16. By Region - Global Generic Drugs Revenue Market Share, 2016-2027
Figure 17. By Country - North America Generic Drugs Revenue Market Share, 2016-2027
Figure 18. By Country - North America Generic Drugs Sales Market Share, 2016-2027
Figure 19. US Generic Drugs Revenue, (US$, Mn), 2016-2027
Figure 20. Canada Generic Drugs Revenue, (US$, Mn), 2016-2027
Figure 21. Mexico Generic Drugs Revenue, (US$, Mn), 2016-2027
Figure 22. By Country - Europe Generic Drugs Revenue Market Share, 2016-2027
Figure 23. By Country - Europe Generic Drugs Sales Market Share, 2016-2027
Figure 24. Germany Generic Drugs Revenue, (US$, Mn), 2016-2027
Figure 25. France Generic Drugs Revenue, (US$, Mn), 2016-2027
Figure 26. U.K. Generic Drugs Revenue, (US$, Mn), 2016-2027
Figure 27. Italy Generic Drugs Revenue, (US$, Mn), 2016-2027
Figure 28. Russia Generic Drugs Revenue, (US$, Mn), 2016-2027
Figure 29. Nordic Countries Generic Drugs Revenue, (US$, Mn), 2016-2027
Figure 30. Benelux Generic Drugs Revenue, (US$, Mn), 2016-2027
Figure 31. By Region - Asia Generic Drugs Revenue Market Share, 2016-2027
Figure 32. By Region - Asia Generic Drugs Sales Market Share, 2016-2027
Figure 33. China Generic Drugs Revenue, (US$, Mn), 2016-2027
Figure 34. Japan Generic Drugs Revenue, (US$, Mn), 2016-2027
Figure 35. South Korea Generic Drugs Revenue, (US$, Mn), 2016-2027
Figure 36. Southeast Asia Generic Drugs Revenue, (US$, Mn), 2016-2027
Figure 37. India Generic Drugs Revenue, (US$, Mn), 2016-2027
Figure 38. By Country - South America Generic Drugs Revenue Market Share, 2016-2027
Figure 39. By Country - South America Generic Drugs Sales Market Share, 2016-2027
Figure 40. Brazil Generic Drugs Revenue, (US$, Mn), 2016-2027
Figure 41. Argentina Generic Drugs Revenue, (US$, Mn), 2016-2027
Figure 42. By Country - Middle East & Africa Generic Drugs Revenue Market Share, 2016-2027
Figure 43. By Country - Middle East & Africa Generic Drugs Sales Market Share, 2016-2027
Figure 44. Turkey Generic Drugs Revenue, (US$, Mn), 2016-2027
Figure 45. Israel Generic Drugs Revenue, (US$, Mn), 2016-2027
Figure 46. Saudi Arabia Generic Drugs Revenue, (US$, Mn), 2016-2027
Figure 47. UAE Generic Drugs Revenue, (US$, Mn), 2016-2027
Figure 48. Global Generic Drugs Production Capacity (K MT), 2016-2027
Figure 49. The Percentage of Production Generic Drugs by Region, 2020 VS 2027
Figure 50. Generic Drugs Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Generic Drugs Segment by Type
Figure 2. Generic Drugs Segment by Application
Figure 3. Global Generic Drugs Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Generic Drugs Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Generic Drugs Revenue, 2016-2027 (US$, Mn)
Figure 7. Generic Drugs Sales in Global Market: 2016-2027 (K MT)
Figure 8. The Top 3 and 5 Players Market Share by Generic Drugs Revenue in 2020
Figure 9. By Type - Global Generic Drugs Sales Market Share, 2016-2027
Figure 10. By Type - Global Generic Drugs Revenue Market Share, 2016-2027
Figure 11. By Type - Global Generic Drugs Price (USD/MT), 2016-2027
Figure 12. By Application - Global Generic Drugs Sales Market Share, 2016-2027
Figure 13. By Application - Global Generic Drugs Revenue Market Share, 2016-2027
Figure 14. By Application - Global Generic Drugs Price (USD/MT), 2016-2027
Figure 15. By Region - Global Generic Drugs Sales Market Share, 2016-2027
Figure 16. By Region - Global Generic Drugs Revenue Market Share, 2016-2027
Figure 17. By Country - North America Generic Drugs Revenue Market Share, 2016-2027
Figure 18. By Country - North America Generic Drugs Sales Market Share, 2016-2027
Figure 19. US Generic Drugs Revenue, (US$, Mn), 2016-2027
Figure 20. Canada Generic Drugs Revenue, (US$, Mn), 2016-2027
Figure 21. Mexico Generic Drugs Revenue, (US$, Mn), 2016-2027
Figure 22. By Country - Europe Generic Drugs Revenue Market Share, 2016-2027
Figure 23. By Country - Europe Generic Drugs Sales Market Share, 2016-2027
Figure 24. Germany Generic Drugs Revenue, (US$, Mn), 2016-2027
Figure 25. France Generic Drugs Revenue, (US$, Mn), 2016-2027
Figure 26. U.K. Generic Drugs Revenue, (US$, Mn), 2016-2027
Figure 27. Italy Generic Drugs Revenue, (US$, Mn), 2016-2027
Figure 28. Russia Generic Drugs Revenue, (US$, Mn), 2016-2027
Figure 29. Nordic Countries Generic Drugs Revenue, (US$, Mn), 2016-2027
Figure 30. Benelux Generic Drugs Revenue, (US$, Mn), 2016-2027
Figure 31. By Region - Asia Generic Drugs Revenue Market Share, 2016-2027
Figure 32. By Region - Asia Generic Drugs Sales Market Share, 2016-2027
Figure 33. China Generic Drugs Revenue, (US$, Mn), 2016-2027
Figure 34. Japan Generic Drugs Revenue, (US$, Mn), 2016-2027
Figure 35. South Korea Generic Drugs Revenue, (US$, Mn), 2016-2027
Figure 36. Southeast Asia Generic Drugs Revenue, (US$, Mn), 2016-2027
Figure 37. India Generic Drugs Revenue, (US$, Mn), 2016-2027
Figure 38. By Country - South America Generic Drugs Revenue Market Share, 2016-2027
Figure 39. By Country - South America Generic Drugs Sales Market Share, 2016-2027
Figure 40. Brazil Generic Drugs Revenue, (US$, Mn), 2016-2027
Figure 41. Argentina Generic Drugs Revenue, (US$, Mn), 2016-2027
Figure 42. By Country - Middle East & Africa Generic Drugs Revenue Market Share, 2016-2027
Figure 43. By Country - Middle East & Africa Generic Drugs Sales Market Share, 2016-2027
Figure 44. Turkey Generic Drugs Revenue, (US$, Mn), 2016-2027
Figure 45. Israel Generic Drugs Revenue, (US$, Mn), 2016-2027
Figure 46. Saudi Arabia Generic Drugs Revenue, (US$, Mn), 2016-2027
Figure 47. UAE Generic Drugs Revenue, (US$, Mn), 2016-2027
Figure 48. Global Generic Drugs Production Capacity (K MT), 2016-2027
Figure 49. The Percentage of Production Generic Drugs by Region, 2020 VS 2027
Figure 50. Generic Drugs Industry Value Chain
Figure 51. Marketing Channels
